<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Endocr Soc</journal-id><journal-id journal-id-type="iso-abbrev">J Endocr Soc</journal-id><journal-id journal-id-type="publisher-id">jes</journal-id><journal-title-group><journal-title>Journal of the Endocrine Society</journal-title></journal-title-group><issn pub-type="epub">2472-1972</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7207456</article-id><article-id pub-id-type="doi">10.1210/jendso/bvaa046.1064</article-id><article-id pub-id-type="publisher-id">bvaa046.1064</article-id><article-categories><subj-group subj-group-type="heading"><subject>Tumor Biology</subject><subj-group subj-group-type="category-toc-heading"><subject>Tumor Biology: General, Tumorigenesis, Progression, and Metastasis</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00250</subject></subj-group></article-categories><title-group><article-title>SAT-147 Endogenous Expression of TCF21 by CRISPR/dCas9 System Results in Different Biological Responses in Adrenocortical Carcinoma and Hepatocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kremer</surname><given-names>Jean Lucas</given-names></name><degrees>PhD Student</degrees><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Passaia</surname><given-names>Barbara dos santos</given-names></name><degrees>PhD student</degrees><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Lotfi</surname><given-names>Claudimara Ferini Pacicco</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="AF0001"/></contrib></contrib-group><aff id="AF0001">
<institution>University of S&#x000e3;o Paulo</institution>, S&#x000e3;o Paulo, <country country="BR">Brazil</country></aff><pub-date pub-type="collection"><day>08</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="epub" iso-8601-date="2020-05-08"><day>08</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>08</day><month>5</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>4</volume><issue>Suppl 1</issue><issue-title>ENDO 2020 ABSTRACTS SCHEDULED FOR THE ANNUAL MEETING OF THE ENDOCRINE SOCIETY &#x02013; MARCH 28 &#x02013; 31, 2020 - SAN FRANCISCO, CALIFORNIA (CANCELLED)</issue-title><elocation-id>SAT-147</elocation-id><permissions><copyright-statement>&#x000a9; Endocrine Society 2020.</copyright-statement><copyright-year>2020</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="bvaa046.1064.pdf"/><abstract><title>Abstract</title><p>Transcription factor 21 (TCF21/POD-1/Epicardin) inhibits the expression of SF-1 (NR5A1) by binding to the promoter E-box site in adrenocortical carcinoma (ACC). In contrast, TCF21 promotes increased expression of LRH-1 in hepatocarcinoma cell line, HepG2 cells, by binding to the Small Heterodimer Partner (SHP/NR0B2) promoter region, an LRH-1 negative regulator. Epigenetic alteration induced TCF21 loss of function and has been associated with increased of cellular migration and invasion. In ACC, TCF21 promoter is hypermethylated and less expressed. Our aim was to evaluate the effect of TCF21 by expressing or silencing TCF21 in adrenocortical pediatric adenoma, ACA-T7 cells, in ACC cell lines SW-13 and H295R cell line, and in HepG2 cell line. Were used CRISPR/dCas9/TCF21 and pCMVMycPOD1 or siRNATCF21 to express and silence TCF21, respectively. Increased expression of TCF21 in H295RpCMVMycPOD1 and SW-13CRISPR/dCas9/TCF21 cells resulted in significantly decreased cell migration and invasion (53.2&#x000b1;36.1%/70.8&#x000b1;26.5% and 82.6&#x000b1;4.2%/100%, respectively). In ACA-T7/siRNATCF21 cells, the inhibition of TCF21 resulted in significant increase migration and invasion capacity (45.0&#x000b1;12.7%/33.1&#x000b1;17.4%) compared with ACA-T7 cells. Higher TCF21 expression in HepG2CRISPR/dCas9/TCF21 increased invasion [147.08&#x000b1;16.54% (p&#x0003c;0.0001)]. Analysis of metalloproteinase genes expression showed that TCF21 significantly (p&#x0003c;0.01) increased MMP8 expression in SW-13CRISPR/dCas9/TCF21 and H295R/pCMVMycPod-1 whereas decreased MMP9 and MMP2 (p&#x0003c; 0.0001). The opposite effect was observed in ACA-T7/siRNATCF21. Moreover, in HepG2CRISPR/dCas9/TCF21 cells was observed an increase of MMP2 and MMP9 expression (p&#x0003c;0.001). These results suggest that TCF21 regulate epithelial mesenchymal transition and vice versa (EMT/MET) in tumors depending on cellular context. Supported by Fapesp and Capes.</p></abstract><counts><page-count count="1"/></counts></article-meta></front></article>